Compare TOMZ & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOMZ | SINT |
|---|---|---|
| Founded | 1979 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.1M |
| IPO Year | 2009 | 2007 |
| Metric | TOMZ | SINT |
|---|---|---|
| Price | $0.80 | $2.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 349.3K | 43.5K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.64 | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,635,927.00 | $1,018,000.00 |
| Revenue This Year | $48.56 | $30.26 |
| Revenue Next Year | $121.37 | $413.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $1.86 |
| 52 Week High | $1.20 | $6.78 |
| Indicator | TOMZ | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 43.05 |
| Support Level | $0.69 | $1.93 |
| Resistance Level | $0.82 | $2.46 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 21.84 | 40.83 |
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.